Estrogen replacement therapy is underutilized among postmenopausal women at high risk for coronary heart disease

American Journal of the Medical Sciences

Volumn 320, Issue 2, 2000, Pages 124-127

  Massey, Clara V ^a   Hupp, Carolyn H ^a   Kreisberg, Mark ^a   Alpert, Martin A ^a   Hoff, Charles ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

Coronary heart disease; Estrogen

Indexed keywords

ESTROGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG UTILIZATION; ESTROGEN THERAPY; FEMALE; HIGH RISK POPULATION; HUMAN; HYSTERECTOMY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; RACE DIFFERENCE; SOCIOECONOMICS;

EID: 0033843127     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200008000-00011     Document Type: Article

References (32)

1. Menopause and heart disease
2. Hormone replacement therapy and the cardiovascular system
3. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women
4. Effects of hormone replacement therapy on cardiovascular risk factors in postmenopausal women
5. Effects of postmenopausal estrogen replacement on the concentration and metabolism of plasma lipoproteins
6. Postmenopausal hormone replacement therapy, coronary heart disease and plasma lipoproteins
7. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women
8. Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. Postmenopausal Estrogen/Progestin Interventions
9. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women
10. Effects of hormone replacement therapy on fibrinolysis in postmenopausal women
11. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women
12. Estrogen improves endothelium-dependent flow mediated vasodilation in postmenopausal women
13. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women
14. Postmenopausal estrogen therapy and cardiovascular disease: Ten year follow-up from the Nurses' Health Study
15. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
16. Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-up Study
17. Decreased mortality in users of estrogen replacement therapy
18. Hormone therapy to prevent disease and prolong life in postmenopausal women
19. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
20. Early menopause and the risk of myocardial infarction
21. Premenopausal hysterectomy and cardiovascular disease
22. Use of menopausal estrogens and medroxyprogesterone in the United States, 1982-1992
23. Use of estrogens among middle-aged Massachusetts women
24. Attitudes of women toward hormone therapy and prevention of heart disease
25. Personal use of postmenopausal hormone replacement therapy by women physicians in the United States
26. Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-up Study
27. Postmenopausal estrogen therapy and cardiovascular disease (ten year follow-up from the Nurses' Health Study)
28. Postmenopausal hormone use for cardioprotection: What we know and what we must learn
29. Coronary heart disease and its risk factors among women in the Framingham Study